Volume 9, Issue 2

Addressing Mental Health in CF

In this issue:

Anxiety and depression in cystic fibrosis — who do these conditions affect? How much do they influence patient health? How can clinicians identify and manage them? What evidence-based interventions have been shown to work?

In this issue, Dr. Anna Georgiopoulos, Assistant Professor of Psychiatry, Part-Time, Harvard Medical School and Consulting Psychiatrist, Massachusetts General Hospital Cystic Fibrosis Program, takes us to the clinic to answer these questions that can be key to the health and well-being of children, adults, and families living with CF.

Learning objectives:

  • Describe how a parent’s mental health can impact their child with cystic fibrosis
  • Summarize the options for treating depression and anxiety in adults with cystic fibrosis


Anna Georgiopoulos, MD
Anna Georgiopoulos, MD

Assistant Professor of Psychiatry, Part-Time
Harvard Medical School
Consulting Psychiatrist
Massachusetts General Hospital Cystic Fibrosis Program
Boston, Massachusetts

Program Directors:

Noah Lechtzin, MD, MHA

Director, Adult Cystic Fibrosis Program
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD

Peter J. Mogayzel, Jr., MD, PhD

Professor of Pediatrics
Director, Cystic Fibrosis Center
Johns Hopkins University School of Medicine
Baltimore, MD

Donna Peeler, RN

Clinical Nurse 
Pediatric Clinic Coordinator 
Johns Hopkins Cystic Fibrosis Center 
Baltimore, MD

Length of activity:

0.5 hour Physicians
0.5 contact hour Nurses

Launch date: May 5, 2020
Expiration date: May 4, 2022